1288:HKEX
ABC
Data as of 2026-03-10 - not real-time
HK$5.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ABC trades at HK$5.17, sitting just above the computed support of HK$5.09 and well below the resistance of HK$5.64, indicating limited upside in the near term. The 20‑day SMA (5.36) has slipped beneath both the 50‑day (5.47) and 200‑day (5.51) averages, confirming a bearish price momentum. Technical momentum is further dampened by a bearish MACD histogram and an RSI of 38, suggesting the stock is approaching oversold territory but has not yet reversed. Volume is on an increasing trend, which could accelerate price moves either way. On the valuation side, the trailing PE of 5.88 is far below the industry average of 17.28, flagging the stock as substantially undervalued. The price‑to‑book of 0.58 and a dividend yield of 5.21% provide additional margin of safety, especially with a modest payout ratio of 31%. However, operating cash flow is strongly negative (‑HK$1.29 trn), raising questions about the sustainability of the dividend despite a net cash position (cash exceeds debt). The stock’s beta of 0.21 and 30‑day volatility of 22.7% point to low systematic risk but relatively high short‑term price swings. Analysts’ consensus remains a “buy” with a mean target price of HK$6.41, implying a potential upside of roughly 24%.
The bearish technical set‑up suggests caution for short‑term traders, while the strong balance‑sheet cushion supports a medium‑to‑long‑term buying case. The “Extreme Greed” market sentiment (fear‑greed index 76.9) may be inflating price expectations, but the large upside/downside estimate of 24% still leaves room for gains. Given the combination of deep valuation discounts, attractive dividend yield, and solid capital position, the stock is positioned favorably for investors with a longer horizon.
The bearish technical set‑up suggests caution for short‑term traders, while the strong balance‑sheet cushion supports a medium‑to‑long‑term buying case. The “Extreme Greed” market sentiment (fear‑greed index 76.9) may be inflating price expectations, but the large upside/downside estimate of 24% still leaves room for gains. Given the combination of deep valuation discounts, attractive dividend yield, and solid capital position, the stock is positioned favorably for investors with a longer horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD and RSI indicating downward pressure
- price near technical support at HK$5.09
- increasing volume suggesting potential acceleration
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- PE well below industry average indicating valuation discount
- net cash surplus despite high debt
- high dividend yield with modest payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- market leadership in Chinese banking sector
- sustainable dividend income
- long‑term growth prospects of Chinese economy
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin48.55%
P/E Ratio5.9
ROE9.37%
ROA0.63%
P/B Ratio0.6
Op. Cash FlowHK$-1287869038592
Industry P/E17.3
Technical Analysis
TrendBearish
RSI38.3
SupportHK$5.09
ResistanceHK$5.64
MA 20HK$5.36
MA 50HK$5.47
MA 200HK$5.51
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Target PriceHK$6.41
Upside/Downside24.01%
GradeUndervalued
TypeValue
Dividend Yield5.21%
Risk Assessment
Beta0.21
Volatility22.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.